Peripheral vascular disease is a blood circulation disorder, which reduces the flow of blood through blood vessels located outside the heart and brain. When these vessels do not supply sufficient blood, it results in the abnormal functioning of organs. Peripheral vascular device are used to measure blood flow from arteries and veins. Peripheral vascular device would be in demand due to its minimally invasive endovascular treatment, rising prevalence of diseases such as diabetes & obesity and growing aging population.
Peripheral vascular device market is segmented based on its types as peripheral stents grafts, angioplasty catheters, Peripheral guidewires, vena cava filters, embolic projection devices, PTA balloons and peripheral venous thrombectomy device. Peripheral vascular stents graft holds the dominant share in the peripheral vascular device market. Angioplasty catheter is the fastest growing segment in the peripheral vascular devices market. Peripheral vascular device market is segmented based on geography. North America holds the dominant share in the peripheral vascular device market followed by Europe. Asia pacific region is expected to grow due to the increasing incidents of peripheral vascular disorders. Peripheral vascular device manufacturers are adopting key development strategies to create next generation devices. Large numbers of clinical trials are in progress to increase the safety and efficacy of devices. Abbott Vascular, Bayer Healthcare, Volcano Corporation and Teleflex Medical are the key players in the peripheral device market.
The Global Peripheral vascular device market is segmented based on types and geography.